High-dose chemotherapy with autologous stem cell support in poor-risk germ cell tumors

Annals of Hematology

Volumn 76, Issue 5, 1998, Pages 183-188

  Siegert, W ^a   Rick, O ^a   Beyer, J ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Autologous stem cell transplantation; Germ cell tumor; High dose chemotherapy

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE;

AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; DIARRHEA; GERM CELL TUMOR; HIGH RISK PATIENT; HUMAN; NEPHROTOXICITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; STOMATITIS;

ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GERMINOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; PROGNOSIS; RISK FACTORS; SALVAGE THERAPY;

EID: 0031812074     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050386     Document Type: Review

References (30)

1. Barnett MJ, Coppin CML, Murray N, Murray N, Nevill TJ, Reece DE, Klingemann HG, Shepherd JD, Nantel SH, Sutherland HJ, Phillips GL (1993) High-dose chemotherapy and autologous bone marrow transplantation for patients with poor-prognosis non-seminomatous germ cell tumors. Br J Cancer 68:594-598
2. Beyer J, Schwella N, Zingsem J, Strohscheer I,Schwaner I, Oettle H, Serke S, Huhn D, Siegen W (1995) Hematopoietic rescue after high-dose chemotherapy using autologous peripheral blood progenitor cells or bone marrow: a randomized comparison. J Clin Oncol 13:1328-1135
3. Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemever C, Schmoll HJ, Nichols CR, Einhorn LH, Siegen W (1996) High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol 14:2638-2645
4. Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegen W (1997) Long-term survival of patients with recurrent or refractory germ cell tumors after high-dose chemotherapy. Cancer 79:161-168
5. Bokemeyer C, Harstrick A, Metzner B, Beyer J, Rüther U, Berdel W, Casper J, Kührer I, Illiger HJ, Kempf B, Föller A, Holstein K, Derigs HG, Schmoll HJ for the German testicular cancer study group (1996) Sequential high-dose VIP chemotherapy plus peripheral stem cell support for advanced germ cell cancer. Ann Oncol 7 [Suppl 5]:55 (abstr 256)
6. Broun ER, Nichols CR, Tricot G, Loehrer PJ, Williams SD, Einhorn LH (1991) High-dose carboplatin/VP16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors. Bone Marrow Transplant 7:53-56
7. Broun ER, Nichols CR, Kneebone P, Williams SD, Loehrer PJ, Einhorn LH, Tricot GJK (1992) Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue. Ann Intern Med 117:124-128
8. Broun ER, Nichols CR, Turns M, Williams SD, Loehrer PJ, Roth BJ, Lazarus HM, Einhorn LH (1994) Early salvage therapy for germ cell cancer using high-dose chemotherapy with autologous bone marrow support. Cancer 73:1716-1720
9. Broun ER, Nichols CR, Mandanas R, Salzman D, Turns M, Hromas R, Cornetta K, Einhorn LH (1995) Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors. Bone Marrow Transplant 16:353-358
10. Broun ER, Nichols CR, Gize G, Kornetta K, Hromas RA, Schacht B, Einhorn LH (1997) Tandem high-dose chemotherapy with autologous hone marrow transplantation for initial relapse of testicular germ cell cancer. Cancer 79:1605-1610
11. Buckner CD, Clift RA, Fefer A, Funk DD, Glucksberg H, Neiman PE, Paulsen A, Storb R, Thomas ED (1974) High-dose cyclophosphamide (NSC26271) for the treatment of metastatic testicular neoplasms. Cancer Chemother Reports 58:709-714
12. Chevreau C, Droz JP, Pico JL, Biron P, Kerbrat P, Curé H, Héron JF, Chevallier B, Fargeot P, Kramar A (1993) Early intensified chemotherapy with autologous hone marrow transplantation in first-line treatment of poor-risk non-seminomatous germ-cell tumors. Preliminary results of a French randomized trial. Eur Urol 23:213-218
13. Elias A, Kantoff P, Ayash L, Schwartz G, Wheeler C, Tepler I, Mazanet R, McCauley D, Frei III E, Antman K (1993) High-dose ifosfamide, carboplatin and etoposide (ICE) with autologous hone marrow support for germ cell carcinoma. Proc Am Soc Clin Oncol 12:231 (abstr 710)
14. Fitzharris BM, Kaye SB, Saverymuttu S, Newlands ES, Barrett A, Peckham MJ, McElwain TJ (1980) VP16-213 as a single agent in advanced testicular tumors. Eur J Cancer 16:1193-1197
15. Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M (1991) Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma. J Clin Oncol 9:1549-1535
16. Linkesch W, Greinix H, Kalhs P, Keil F, Krainer M (1994) Long-term results of phase I/II trial of CarboPEC with ABMT in refractory or relapsed NSGCT. Bone Marrow Transplant 14 [Suppl]:S41
17. Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH (1988) Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109:540-546
18. Lotz JP, André T, Donsimone R, Firmin C, Bouleuc C, Bonnak H, Merad Z, Esteso A, Gerota J, Izrael V (1995) High-dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer 75:874-885
19. Margolin K, Doroshow JH, Ahn C, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shihata S, Somlo G, Tetef M (1996) Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support. J Clin Oncol 14:2631-2637
20. Motzer RJ, Cooper K, Geller NL, Bajorin DF, Dmitrovsky E, Herr H, Morse M, Fair W, Sogani P, Russo P (1990) The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 66:2476-2481
21. Motzer RJ, Gulati SC, Crown JP, Weisen S, Doherty M, Herr H, Fair W, Sheinfeld J, Sogani P, Russo P, Bosl GJ (1992) High-dose chemotherapy and autologous hone marrow rescue for patients with refractory germ cell tumors: early intervention is better tolerated. Cancer 69:550-556
22. Motzer RJ, Mazumdar M, Gulati SC, Bajorin DF, Lyn P, Vlamis V, Bosl GJ (1993) Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Natl Cancer Inst 85:1828-1835
23. Motzer RJ, Mazumdar M, Bosl GJ, Bajorin DF, Amsterdam A, Vlamis V (1996) High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J Clin Oncol 14:1098-1105
24. Motzer RJ, Mazumdar M, Bajorin DF, Bosl GJ, Lyn P, Vlamis V (1997) High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Clin Oncol 15:2546-2552
25. Nichols CR, Tricot G, Williams SD, van Besien K, Loehrer PJ, Roth BJ, Akard L, Hoffman R, Goulet R, Wolff SN, Giannone L, Greer J, Einhorn LH, Jansen J (1989) Dose-intensive chemotherapy in refractory germ cell cancer - a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932-939
26. Nichols CR, Andersen J, Lazarus HM, Fisher H, Greer J, Stadtmauer EA, Loehrer PJ, Trump DL (1992) High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Oncology Group protocol. J Clin Oncol 10:558-563
27. Rosti G, Albertazzi L, Salvioni R, Pizzocaro G, Cetto GL, Bassetto MA, Marangolo M (1992) High-dose chemotherapy with autologous bone marrow transplantation in germ cell tumors: a phase II study. Ann Oncol 3:809-812
28. Shea TC, Flaherty M, Elias A, Eder JP, Antman K, Begg C (1989) A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support. J Clin Oncol 7:651-661
29. Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D (1994) High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. J Clin Oncol 12:1223-1231
30. Wheeler BM, Loehrer P, Williams SD, Einhorn LH (1986) Ifosfamide in refractory male germ cell tumors. J Clin Oncol 4:28-34